Results for drug-maker: 26

* To obtain supplies of Tamiflu for 12 million more people * Additional supply is triple the amount shipped last season * Chugai shares rise 0.5 pct, versus Nikkei's 1.3 pct gain TOKYO, Sept 7...

*To obtain supplies of Tamiflu for 12 million more people *In addition to current stocks, supply 3 times last season *Chugai shares up 0.5 pct, versus Nikkei 1 pct gain TOKYO, Sept 7 - Japan's...

SYDNEY, Sept 7 - Australian drug maker and distributor Sigma Pharmaceuticals Ltd <SIP.AX> plans to raise A$297 million ($254 million) in a one-for-three rights offer to part fund an acquisition, the company said on Monday....

SYDNEY, Sept 7 - Australian drug maker and distributor Sigma Pharmaceuticals Ltd <SIP.AX> plans to make an announcement regarding an acquisition and a potential capital raising, the company said in a statement on Monday. Sigma...

* Novartis says one H1N1 vaccine dose might be enough * Sinovac gets green light from Chinese regulators * Single shot immunisation would ease supplies * Sinovac shares up 16 percent; Novartis falls slightly ZURICH/BEIJING,...

* Novartis says one H1N1 vaccine dose might be enough * Sinovac gets green light from Chinese regulators * Single shot immunisation would ease supplies * Sinovac shares up 16 percent; Novartis falls slightly ZURICH/BEIJING,...

* Novartis says one H1N1 vaccine dose might suffice * Sinovac gets green light from Chinese regulators * Single shot immunisation would ease supplies (Wraps Novartis, Sinovac stories, adds CSL details, background) ZURICH/BEIJING, Sept 3...

* Japanese will gain big Sepracor U.S. sales force * Bid is friendly, with both boards approving * Looking to promote experimental schizophrenia drug * 2nd-biggest Japanese overseas acquisition this year * Sepracor +26 pct...

* Says pilot vaccine trial gives strong immune response * Says one dose might be enough, vaccine well tolerated * Single shot immunisation would stretch out tight supplies ZURICH, Sept 3 - Novartis's vaccine against...

* Latest Japanese pharma buy in U.S. is friendly * Looking to promote experimental schizophrenia drug * Sepracor shares jump 26 pct before halt * Dainippon up 2 pct, Nikkei off 0.4 pct (Updates with...